We are live on ! Find out more
Vanguard Global Advisers

Vanguard Global Advisers Portfolio holdings

AUM $215B
This Fund
S&P 500
This Quarter Est. Return
+22.32%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215B
AUM Growth
+$28.1B
Cap. Flow
+$1.96B
Cap. Flow %
0.91%
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189M
2
HON icon
Honeywell
HON
+$157M
3
AAPL icon
Apple
AAPL
+$124M
4
MSFT icon
Microsoft
MSFT
+$89M
5
AMZN icon
Amazon
AMZN
+$62.1M

Sector Composition

Rank Sector Weight
1 Technology 25.83%
2 Miscellaneous 25.2%
3 Financials 11.43%
4 Communication Services 6.64%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTX icon
3526
Context Therapeutics
CNTX
$27.6M
$6.99K ﹤0.01%
12,612
– –
QRHC icon
3527
Quest Resource Holding
QRHC
$28.7M
$6.93K ﹤0.01%
5,500
– –
MRDN
3528
Meridian Holdings Inc
MRDN
$154M
$6.9K ﹤0.01%
496
– –
CDLX icon
3529
Cardlytics
CDLX
$17.3M
$6.88K ﹤0.01%
1,532
– –
NAII icon
3530
Natural Alternatives International
NAII
$9.33M
$6.74K ﹤0.01%
2,819
– –
DYAI icon
3531
Dyadic International
DYAI
$17.8M
$6.62K ﹤0.01%
7,385
– –
TVRD
3532
Tvardi Therapeutics
TVRD
$16.7M
$6.46K ﹤0.01%
3,400
– –
GLOO
3533
Gloo Holdings Inc
GLOO
$392M
$6.3K ﹤0.01%
1,385
– –
DARE icon
3534
Dare Bioscience
DARE
$16.8M
$6.2K ﹤0.01%
2,940
– –
FRBT
3535
Forbright Inc
FRBT
$865M
$6.09K ﹤0.01%
+333
New +$6.03K
ATOS icon
3536
Atossa Therapeutics
ATOS
$19.5M
$5.96K ﹤0.01%
3,089
– –
ACCS
3537
ACCESS Newswire
ACCS
$18M
$5.91K ﹤0.01%
909
– –
RMTI icon
3538
Rockwell Medical
RMTI
$34.4M
$5.83K ﹤0.01%
1,057
– –
REFR icon
3539
Research Frontiers
REFR
$25.6M
$5.78K ﹤0.01%
11,108
– –
DLO icon
3540
dLocal
DLO
$4.05B
$5.77K ﹤0.01%
444
-44
-9% -$558
LIVE icon
3541
Live Ventures
LIVE
$23.3M
$5.76K ﹤0.01%
601
– –
AUID icon
3542
authID Inc
AUID
$6.36M
$5.76K ﹤0.01%
5,385
– –
LEXX icon
3543
Lexaria Bioscience
LEXX
$6.64M
$5.71K ﹤0.01%
680
– –
LASE icon
3544
Laser Photonics
LASE
$51.7M
$5.63K ﹤0.01%
3,413
– –
NTIP icon
3545
Network-1 Technologies
NTIP
$36.6M
$5.59K ﹤0.01%
3,800
– –
CIRC
3546
Circle8 Group
CIRC
$54M
$5.29K ﹤0.01%
5,747
– –
VRCA icon
3547
Verrica Pharmaceuticals
VRCA
$82.3M
$5.28K ﹤0.01%
862
– –
CTSO icon
3548
Cytosorbents Corp
CTSO
$12.3M
$5.19K ﹤0.01%
693
– –
KPLT icon
3549
Katapult Holdings
KPLT
$371M
$5.18K ﹤0.01%
783
– –
NNVC icon
3550
NanoViricides
NNVC
$33.2M
$5.12K ﹤0.01%
3,712
– –

Similar funds

Vanguard Global Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Financials.

  • Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
  • Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
  • Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
  • Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
  • Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
  • Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
  • Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.